Supernus Pharmaceuticals | Passifs Courants



Current Liabilities Changement Date
Abbott USD 13B 1.15B 2025-03
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Eisai JPY 381.62B 54.78B 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
Indivior 1.01B 66M 2025-03
Novo Nordisk 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
United Therapeutics USD 721.5M 16.6M 2025-03
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12



Supernus Pharmaceuticals Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.